FDA CNPRV Criteria May Mirror RFK Jr.’s Push To Curb Overprescribing

By Maaisha Osman / July 25, 2025 at 2:31 PM

One of the FDA’s criteria for awarding priority review vouchers under its new program for companies that address national priorities -- reducing “downstream medical utilization” -- is raising eyebrows, with some industry observers saying the vague cost-saving goal appears to echo HHS Secretary Robert F. Kennedy Jr.’s campaign to rein in drug overprescribing.


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.